1. Clinical Overview
Flupenthixol + Melitracen is a fixed-dose combination (FDC) of a thioxanthene neuroleptic (Flupenthixol) and a tricyclic antidepressant (Melitracen). It is primarily used for the treatment of mixed anxiety-depressive disorders, dysthymia, and psychosomatic disorders. The combination is designed to provide a balanced effect, where Flupenthixol elevates mood and reduces anxiety, while Melitracen provides antidepressant and anxiolytic effects. It is a widely prescribed psychotropic medication in the Indian outpatient setting for mild to moderate neurotic conditions.
| Onset | Duration | Bioavailability |
|---|---|---|
| Onset of therapeutic effect is typically observed within 2-4 hours for initial calming effects, with full antidepressant effects manifesting over 2-4 weeks of continuous therapy. | The duration of action is approximately 24-48 hours, supporting once-daily or twice-daily dosing regimens. | Flupenthixol: Approximately 40-55% orally. Melitracen: Approximately 70-80% orally. |
2. Mechanism of Action
The combination works via complementary mechanisms. Flupenthixol is a potent dopamine D1 and D2 receptor antagonist, which at low doses modulates dopaminergic neurotransmission, leading to mild antipsychotic, mood-stabilizing, and activating effects. Melitracen is a tricyclic antidepressant that primarily inhibits the reuptake of noradrenaline (norepinephrine) and, to a lesser extent, serotonin in the presynaptic neurons, thereby increasing their synaptic concentrations. The net effect is an improvement in mood, reduction in anxiety and psychomotor retardation, without significant sedation at standard doses.
3. Indications & Uses
- Mixed Anxiety and Depressive Disorder (MADD)
- Dysthymia (Persistent Depressive Disorder)
- Adjustment disorders with depressed mood and anxiety
- Neurotic disorders with associated depressive symptoms
4. Dosage & Administration
Adult Dosage: One tablet (Flupenthixol 0.5 mg + Melitracen 10 mg) twice daily, usually morning and afternoon. In milder cases, one tablet once daily (morning) may suffice. Maximum: 3 tablets per day.
Administration: Administer orally with or after food to minimize gastric upset. The last dose should not be taken too late in the evening to avoid potential sleep disturbances due to the activating effect of Flupenthixol. Tablet can be split for dose titration. Do not crush or chew unless scored.
5. Side Effects
Common side effects may include:
- Dry mouth
- Constipation
- Blurred vision (transient)
- Dizziness or lightheadedness (especially on standing)
- Drowsiness or sedation (usually transient)
- Increased sweating
- Weight gain
- Restlessness (akathisia)
6. Drug Interactions
| Drug | Effect | Severity |
|---|---|---|
| Monoamine Oxidase Inhibitors (MAOIs) - e.g., Phenelzine, Selegiline | Risk of hypertensive crisis, serotonin syndrome, hyperpyrexia. | Contraindicated |
| Other CNS Depressants (Alcohol, Benzodiazepines, Opioids) | Additive CNS depression, impaired alertness, respiratory depression. | Major |
| Anticholinergic drugs (e.g., Atropine, Trihexyphenidyl, TCAs) | Increased risk of severe anticholinergic effects (ileus, hyperthermia, confusion). | Major |
| Antihypertensives (especially Alpha-blockers, Guanethidine) | Potentiated hypotensive effect, risk of severe orthostasis. | Moderate |
| QT-prolonging drugs (e.g., Class IA/III antiarrhythmics, Macrolides, Fluoroquinolones) | Additive risk of QT prolongation and torsades de pointes. | Major |
| SSRIs/SNRIs (e.g., Fluoxetine, Sertraline, Venlafaxine) | Increased serotonergic activity, risk of serotonin syndrome. | Moderate |
| Enzyme Inducers (e.g., Carbamazepine, Phenytoin, Rifampicin) | Reduced plasma levels of both Flupenthixol and Melitracen, decreasing efficacy. | Moderate |
| Enzyme Inhibitors (e.g., Fluoxetine, Paroxetine, Cimetidine) | Increased plasma levels, risk of toxicity. | Moderate |
| Sympathomimetics (e.g., Adrenaline, Noradrenaline) | Exaggerated pressor response, arrhythmias. | Moderate |
| Levodopa and Dopamine Agonists | Antagonized therapeutic effect in Parkinson's disease. | Major |
7. Patient Counselling
- DO take the medication exactly as prescribed by your doctor.
- DO take it with food if you experience stomach upset.
- DO inform all your doctors and dentists that you are taking this medicine.
- DO keep follow-up appointments for monitoring.
- DON'T stop taking the medicine suddenly without consulting your doctor.
- DON'T consume alcohol while on this medication.
- DON'T drive or operate machinery until you know how the medicine affects you.
- DON'T take any other prescription, OTC, or herbal medicine without checking with your doctor/pharmacist.
8. Toxicology & Storage
Overdose: Symptoms are an extension of pharmacologic effects and can be severe. Includes: Severe CNS depression (coma), agitation, confusion, hallucinations, seizures, severe anticholinergic symptoms (hyperthermia, flushed skin, mydriasis, ileus, urinary retention), cardiac abnormalities (tachycardia, arrhythmias, hypotension, conduction delays leading to heart block, QT prolongation), respiratory depression, and circulatory collapse. Neuroleptic Malignant Syndrome (NMS) may be triggered.
Storage: Store at room temperature (15-30°C), protected from light and moisture. Keep the bottle tightly closed. Keep out of reach of children and pets. Do not use after the expiry date printed on the pack. Do not flush unused medication down the toilet. Dispose of as per local regulations or through a medicine take-back program.